Novartis Home

Dr Helen Yifter, measuring blood pressure at Black Lion Hospital, Ethiopia

At Novartis, we are reimagining medicine

Life Science Companies and the Bill & Melinda Gates Foundation: Joint Communique

Commitments to expanded global access for COVID-19 diagnostics, therapeutics, and vaccines.

Learn More

Novartis COVID-19 Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.

Enter

World Heart Day 2020: From our heart to yours

For the past six decades, Novartis has been working to advance heart health around the world.

Learn More

Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond

Read More

ESG - Committed to increasing access

Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond, a first in the healthcare industry.

Learn More

AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy

Learn More

Our commitment to doing what's right

Novartis is committed to ensuring our associates are empowered to do what’s right. On September 01, 2020, we introduced a new Code of Ethics for Novartis.

Learn More

Cell & Gene Therapy Explained

What if medicine for certain diseases only needed to be taken once?

Learn More

Novartis at ESMO

Find the latest oncology resources on Novartis data featured at the European Society for Medical Oncology (ESMO).

Read More